期刊文献+

血液净化患者自体动静脉内瘘感染的临床特点及致病菌分布分析

Clinical characteristics and pathogen distribution of autogenous arteriovenous fi stula infection in patients under blood purifi cation
下载PDF
导出
摘要 目的研究血液净化患者自体动静脉内瘘感染的临床特点及致病菌分布。方法选择遂宁市中心医院2019年1月—2021年5月进行血液净化的慢性肾衰竭患者125例进行回归性研究,依据临床自体动静脉内瘘感染诊断标准将患者分成2组,感染组12例,未感染组113例。比较2组的一般资料和发生自体动静脉内瘘感染的危险因素,分析自体动静脉内瘘感染的致病菌分布情况。结果2组年龄(t=31.796,P<0.001)、糖尿病(χ^(2)=15.379,P<0.001)、高血压(χ^(2)=5.071,P<0.001)、白蛋白(t=12.789,P<0.001)差异有统计学意义。较高的年龄(OR=2.773,95%CI:1.369~5.616)、较低的白蛋白水平(OR=0.330,95%CI:0.163~0.667)和存在糖尿病(OR=2.886,95%CI:1.700~4.900)、高血压疾病(OR=1.448,95%CI:1.100~1.905)均是自体动静脉内瘘感染的危险因素(P均<0.05)。感染组主要以革兰氏阳性菌感染为主,其中以金黄色葡萄菌以及表皮葡萄球菌作为优势菌群。病原菌鉴定分型结果表明,感染组革兰氏阳性菌中金黄色葡萄菌、表皮葡萄球菌、溶血葡萄球菌及粪肠球菌对青霉素、阿莫西林、头孢唑林、哌拉西林、红霉素、庆大霉素、克林霉素及环丙沙星耐药情况较为明显。结论血液净化患者治疗中,主要以革兰氏阳性菌感染为主,其中以金黄色葡萄菌和表皮葡萄球菌作为优势菌群。其对青霉素、阿莫西林、头孢唑林、哌拉西林、红霉素、庆大霉素、克林霉素和环丙沙星耐药情况较为明显。 Objective To study the clinical characteristics and pathogen distribution of autogenous arteriovenous fistula infection in patients with dietary blood purification.Methods This trial is a prospective case study,125 patients with chronic renal failure who underwent blood purification in suining central hospital from January 2019 to May 2021 were selected as the subjects.According to clinical diagnostic criteria for autogenous arteriovenous fistula infection,12 patients in the infected group and 113 patients in the uninfected group were enrolled.The general data and risk factors of autogenous arteriovenous fistula infection were compared between the two groups,and the distribution of pathogenic bacteria in patients with autogenous arteriovenous fistula infection was analyzed.Results There were statistically significant differences in age(t=31.796,P<0.001),diabetes mellitus(χ^(2)=15.379,P<0.001),hypertension(χ^(2)=5.071,P<0.001)and albumin(t=12.789,P<0.001)between the infected and uninfected groups.Higher age(OR=2.773,95%CI:1.369~5.616),lower albumin level(OR=0.330,95%CI:0.163~0.667),diabetes(OR=2.886,95%CI:1.700~4.900),hypertension(OR=1.448,95%CI:1.100~1.905)were risk factors for autologous arteriovenous fistula infection(all P<0.05).The pathogenic bacteria in the infected group were analyzed,and it was found that thepatients were mainly infected with gram-positive bacteria,among which Staphylococcus aureus and Staphylococcus epidermidis were the dominant bacterial groups.The results showed that the Gram-positive bacteria,Staphylococcus aureus,Staphylococcus epidermidis,Staphylococcus haemolyticus and Enterococcus faecalis in the infected group were more resistant to penicillin,amoxicillin,cefazolin,piperacillin,erythromycin,gentamicin,clindamycin and ciprofloxacin.Conclusion In the treatment of blood purification patients,Gram-positive bacteria infection was the main one,among which Staphylococcus aureus and Staphylococcus epidermidis were the dominant bacterial groups.Resistance to penicillin,amoxicillin,cefazolin,piperacillin,erythromycin,gentamicin,clindamycin,and ciprofloxacin is more obvious.
作者 夏玲 刘岚 杨艳 XIA Ling;LIU Lan;YANG Yan(Blood Purifi cation Center of Nephrology,Suining Central Hospital,Suining 629000,China)
出处 《空军航空医学》 2024年第5期431-434,共4页 AVIATION MEDICINE OF AIR FORCE
关键词 血液净化 自体动静脉内瘘感染 危险因素 菌群分布 耐药 Blood purification Autogenous arteriovenousfistula infection Risk factors Flora distribution Drug resistance
  • 相关文献

参考文献11

二级参考文献85

  • 1苏红,吴灏,黄军月,郭志勇,李保春.动静脉内瘘穿刺间距选择与再循环发生的护理问题[J].中国血液净化,2007,6(7):401-403. 被引量:14
  • 2Golomb BA, Dang TI', Criqui MH. Peripheral arterial disease: morbidity andmortality implications [ J ]. Circulation, 2006, 114 (7) :688-699.
  • 3Linden E, Cai W, He JC, et al. Endothelial dysfunction in patients with chronic kidney disease results from advanced glyeation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation [ J ]. Clin J Am SocNephrol, 2008,3(3) :691-698.
  • 4Schmidt AM, Hori O, Chen JX, et al. Advanced glycation end- products interacting with their endothelial receptor induce expres- sion of vascular cell adhesion molecule-1 ( VCAM-1 ) in culturedhuman endothelial cells and in mice accelerated vaseulopathy of diabetes (3) :1395-1403.
  • 5Wilson AM, Kimura E, Harada RK, et al. 132-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies [ J]. Circulation, 2007,116(12) : 1396-1403.
  • 6Ducloux D, Bresson-Vautrin C, Kribs M , et al. C-reactive protein and cardiovascular disease in peritoneal dialysis patients [ J]. Kid- ney Int, 2002,62 (4) : 1417-1422.
  • 7Reis JP, Von Mtlhlen D, MichoS ED, et al. Serum vitamin D, par- athyroid hormone levels, and carotid atherosclerosis [ J ]. Athero- sclerosis, 2009,207 (2) :585-590.
  • 8Rammos G, Tseke P, Ziakka S. Vitamin D, the renin-angiotensin system, and insulin resistance [ J ]. Int Urol Nephrol, 2008,40 (2) :419-426.
  • 9Guessous I, Bochud M, Bonny O, et al. Calcium, vitamin D and cardiovascular disease [ J]. Kidney Blood Press Res, 20tl, 34 (6) :404-417.
  • 10I)anescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus [ J]. Endocrine, 2009,35 ( 1 ) : 11-17.

共引文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部